546 related articles for article (PubMed ID: 15472346)
21. Changes in the natural history of invasive pulmonary aspergillosis in neutropenic leukemic patients.
Ruchlemer R; Yinnon AM; Hershko C
Isr J Med Sci; 1996 Nov; 32(11):1089-92. PubMed ID: 8960078
[TBL] [Abstract][Full Text] [Related]
22. Successful management of postpneumonectomy Aspergillus pleural empyema by combined surgical and anti-fungal treatment with voriconazole and caspofungin.
Bonatti H; Lass-Floerl C; Angerer K; Singh N; Lechner M; Stelzmueller I; Singh R; Schmid T; Geltner C
Mycoses; 2010 Sep; 53(5):448-54. PubMed ID: 19496935
[TBL] [Abstract][Full Text] [Related]
23. [The value of surgery in the treatment of invasive pulmonary aspergillosis in neutropenic patients].
Bernard A; Caillot D; Casasnovas O; Couaillier JF; Guy H; Favre JP
Rev Mal Respir; 1998 Feb; 15(1):49-55. PubMed ID: 9551514
[TBL] [Abstract][Full Text] [Related]
24. Cutaneous aspergillosis in a lung transplant recipient.
Ramos A; Ussetti P; Laporta R; Lázaro MT; Sánchez-Romero I
Transpl Infect Dis; 2009 Oct; 11(5):471-3. PubMed ID: 19622116
[TBL] [Abstract][Full Text] [Related]
25. Secondary prophylaxis with voriconazole in a leukemic patient with pulmonary aspergillosis.
Uriz J; de Andoin NG; Calvo C; Landa J; Onate E; Nogues A; Guerrero R
Pediatr Infect Dis J; 2007 Oct; 26(10):971-2. PubMed ID: 17901816
[No Abstract] [Full Text] [Related]
26. Strategy of following voriconazole versus amphotericin B therapy with other licensed antifungal therapy for primary treatment of invasive aspergillosis: impact of other therapies on outcome.
Patterson TF; Boucher HW; Herbrecht R; Denning DW; Lortholary O; Ribaud P; Rubin RH; Wingard JR; DePauw B; Schlamm HT; Troke P; Bennett JE; ;
Clin Infect Dis; 2005 Nov; 41(10):1448-52. PubMed ID: 16231256
[TBL] [Abstract][Full Text] [Related]
27. Invasive pulmonary aspergillosis in neutropenic patients during hospital construction: before and after chemoprophylaxis and institution of HEPA filters.
Oren I; Haddad N; Finkelstein R; Rowe JM
Am J Hematol; 2001 Apr; 66(4):257-62. PubMed ID: 11279636
[TBL] [Abstract][Full Text] [Related]
28. Use of voriconazole to successfully treat disseminated Trichosporon asahii infection in a patient with acute myeloid leukaemia.
Fournier S; Pavageau W; Feuillhade M; Deplus S; Zagdanski AM; Verola O; Dombret H; Molina JM
Eur J Clin Microbiol Infect Dis; 2002 Dec; 21(12):892-6. PubMed ID: 12525928
[TBL] [Abstract][Full Text] [Related]
29. Surgical resection for successful treatment of invasive pulmonary aspergillosis: report of 3 cases.
Metin KS; Ugurlu BS; Kabakci B; Sariosmanoglu NO; Hazan E; Oto O
Scand J Infect Dis; 2005; 37(9):694-6. PubMed ID: 16126574
[TBL] [Abstract][Full Text] [Related]
30. Breakthrough disseminated Aspergillus ustus infection in allogeneic hematopoietic stem cell transplant recipients receiving voriconazole or caspofungin prophylaxis.
Pavie J; Lacroix C; Hermoso DG; Robin M; Ferry C; Bergeron A; Feuilhade M; Dromer F; Gluckman E; Molina JM; Ribaud P
J Clin Microbiol; 2005 Sep; 43(9):4902-4. PubMed ID: 16145172
[TBL] [Abstract][Full Text] [Related]
31. Efficacy of voriconazole against invasive pulmonary aspergillosis in a guinea-pig model.
Chandrasekar PH; Cutright J; Manavathu E
J Antimicrob Chemother; 2000 May; 45(5):673-6. PubMed ID: 10797091
[TBL] [Abstract][Full Text] [Related]
32. [Successful treatment by voriconazole for pulmonary aspergilloma of elderly patient].
Hashimoto M; Honda Y; Fujishima T
Nihon Kokyuki Gakkai Zasshi; 2007 Dec; 45(12):957-61. PubMed ID: 18186242
[TBL] [Abstract][Full Text] [Related]
33. Aspergillus fumigatus-related spondylodiscitis in a heart transplant patient successfully treated with voriconazole.
Wéclawiak H; Garrouste C; Kamar N; Linas MD; Tall P; Dambrin C; Durand D; Rostaing L
Transplant Proc; 2007 Oct; 39(8):2627-8. PubMed ID: 17954195
[TBL] [Abstract][Full Text] [Related]
34. Successful outcome of Scedosporium apiospermum disseminated infection treated with voriconazole in a patient receiving corticosteroid therapy.
Muñoz P; Marín M; Tornero P; Martín Rabadán P; Rodríguez-Creixéms M; Bouza E
Clin Infect Dis; 2000 Dec; 31(6):1499-501. PubMed ID: 11096022
[TBL] [Abstract][Full Text] [Related]
35. [Treatment of invasive fungal infections with voriconazole. Evaluation of experience with compassionate use of voriconazole in Spain].
Díaz Pedroche C; Cisneros JM; Lumbreras C; Aguado JM;
Rev Esp Quimioter; 2005 Jun; 18(2):149-58. PubMed ID: 16130037
[TBL] [Abstract][Full Text] [Related]
36. A novel cause of invasive pulmonary infection in an immunocompetent patient: Aspergillus candidus.
Ribeiro SC; Santana AN; Arriagada GH; Martins JE; Takagaki TY
J Infect; 2005 Nov; 51(4):e195-7. PubMed ID: 16291268
[TBL] [Abstract][Full Text] [Related]
37. Severe primary cutaneous aspergillosis refractory to amphotericin B and the successful treatment with systemic voriconazole in two premature infants with extremely low birth weight.
Frankenbusch K; Eifinger F; Kribs A; Rengelshauseu J; Roth B
J Perinatol; 2006 Aug; 26(8):511-4. PubMed ID: 16871222
[TBL] [Abstract][Full Text] [Related]
38. Aspergillus brain abscess in a patient with acute myeloid leukaemia successfully treated with voriconazole.
Wandroo F; Stableforth P; Hasan Y
Clin Lab Haematol; 2006 Apr; 28(2):130-3. PubMed ID: 16630219
[TBL] [Abstract][Full Text] [Related]
39. Superiority of voriconazole over amphotericin B in the treatment of invasive aspergillosis after heart transplantation.
Wieland T; Liebold A; Jagiello M; Retzl G; Birnbaum DE
J Heart Lung Transplant; 2005 Jan; 24(1):102-4. PubMed ID: 15653389
[TBL] [Abstract][Full Text] [Related]
40. Disseminated invasive aspergillosis in an apparently immunocompetent host.
Raja NS; Singh NN
J Microbiol Immunol Infect; 2006 Feb; 39(1):73-7. PubMed ID: 16440127
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]